{"createdAt":"8/2/2020, 2:33:31 PM","timestamp":1596393211275,"Company ID number":"610","DMX_ISSUER_NAME":"Changchun High & New Technology Industries (Group) Inc.","DMX_ISSUER_ID":"IID000000002161534","Country of Classification":"CHINA","name":"Changchun High & New Technology Industries Group Inc ","code":"000661","stock_exchange":"Shenzhen Stock Exchange","people":[{"id":"长春高新技术产业(集团)股份有限公司_马骥","group":"board","name":"马骥","title":"董事长,董事","isMale":true,"age":"55","degree":"硕士","salary":"223.2万","stockAmount":"1.53万","description":"马骥,男,汉族,1965年4月出生,中共党员,高级工程师,工学硕士学位。现任长春高新技术产业(集团)股份有限公司总经理。主要工作经历包括:1986年任吉林建筑工程学院教师;1993年任中国吉林国际经济技术合作公司海外工程部项目经理、办公室副主任;1997年始任中国吉林国际合作(集团)股份有限公司工程总承包公司综合业务处处长、副总经理、总经理;2003年任长春高新技术产业发展总公司总经理助理、副总经理;2008年始历任长春高新区国资委副主任、长春高新技术产业发展总公司总经理、长春高新技术产业(集团)股份有限公司第六届董事会董事;2011年始历任长春高新技术产业开发区管委会主任助理长东北核心区管委会主任、中共长春市宽城区奋进乡委员会书记;2016年至2017年任长春北湖科技开发区党工委书记。","lastUpdated":"2018-06-27"},{"id":"长春高新技术产业(集团)股份有限公司_安吉祥","group":"board","name":"安吉祥","title":"董事","isMale":true,"age":"59","degree":"","salary":"190.8万","stockAmount":"5.95万","description":"安吉祥,男,汉族,中共党员,1961年3月出生,现任长春高新技术产业(集团)股份有限公司第八届董事会董事、常务副总经理。主要工作经历包括:长春高新技术产业开发区管委会财政局副局长、长春高新技术产业(集团)股份有限公司财务部部长、长春医药集团总裁助理。","lastUpdated":"2018-06-27"},{"id":"长春高新技术产业(集团)股份有限公司_姜云涛","group":"board","name":"姜云涛","title":"董事","isMale":true,"age":"46","degree":"硕士","salary":"169.2万","stockAmount":"2.26万","description":"姜云涛,男,汉族,中共党员,1974年4月出生,吉林大学管理学院工业工程专业工程硕士学位,现任长春高新技术产业(集团)股份有限公司党委副书记。主要工作经历包括:1997年任吉林建工学院城建系团委书记;2001年任长春高新建设开发有限公司办公室主任;2003年任长春高新技术产业发展总公司办公室主任;2007年任长春高新房屋拆迁有限公司经理;2010年任长春高新区建委市政公用设施管理处副处长;2011年任长春高新区南区管委会副主任兼办公室主任;2012年任长春高新区文化旅游园区管理办公室主任;2015年任长春高新技术产业(集团)股份有限公司总经理助理;2016年至2018年任长春高新技术产业(集团)股份有限公司党委副书记。","lastUpdated":"2018-06-27"},{"id":"长春高新技术产业(集团)股份有限公司_王志刚","group":"board","name":"王志刚","title":"董事","isMale":true,"age":"48","degree":"","salary":"136.8万","stockAmount":"4.65万","description":"王志刚,男,汉族,1972年10月出生,中共党员,高级工程师,现任长春高新技术产业(集团)股份有限公司董事、副总经理、长春高新房地产开发有限公司总经理。主要工作经历包括:2000年任长春星宇集团西宇建设公司经理;2001年任长春星宇集团房地产开发有限责任公司副总经理;2004年历任长春融创置地有限公司副总经理、总经理、董事长;2013年至今任长春高新房地产开发有限公司总经理。","lastUpdated":"2018-06-27"},{"id":"长春高新技术产业(集团)股份有限公司_张玉智","group":"board","name":"张玉智","title":"董事","isMale":true,"age":"54","degree":"博士","salary":"--","stockAmount":"-","description":"张玉智,男,汉族,1966年10月出生,中共党员,情报学博士。曾就职于吉林省粮油供应公司、吉林省粮油储运公司、吉林工学院工商管理学院,曾任长春工业大学副教授、经济管理学院副院长。现任长春工业大学经济管理学院院长,教授,博士生导师。","lastUpdated":"2020-04-17"},{"id":"长春高新技术产业(集团)股份有限公司_祝先潮","group":"board","name":"祝先潮","title":"董事","isMale":true,"age":"55","degree":"博士","salary":"6.000万","stockAmount":"-","description":"祝先潮(英文名JeffXianchaoZhu),男,美国国籍,1965年12月出生,美国加州大学,分子生物学生物化学,博士研究生。1996年9月-1998年8月:美国圣地亚哥BD生物科学部,重组蛋白研发科学家;1998年8月-2011年6月:美国辉瑞公司圣地亚哥,新药研发中心/新型疫苗研发中心,首席科学家(Principalscientist),蛋白质科学部门负责人;2011年6月-2013年11月:华兰生物工程股份有限公司,首席科学官,研发中心负责人;2013年12月-2016年05月:美国药典委员会上海研发中心,生物药部负责人,高级总监;2016年06月-至今:浙江博和瑞达生物科技有限公司,董事长兼总经理;2017年9月-至今:上海瑞宙生物科技有限公司,副董事长、总经理。","lastUpdated":"2019-03-29"},{"id":"长春高新技术产业(集团)股份有限公司_程松彬","group":"board","name":"程松彬","title":"独立董事","isMale":true,"age":"63","degree":"博士","salary":"14.40万","stockAmount":"-","description":"程松彬,男,汉族,1957年1月出生,中共党员,经济学(金融)硕士、法学博士、研究员。曾任吉林省政府发展研究中心财贸处副处长、处长,吉林省国际经济技术合作公司投资部经理,吉林省国际信托投资公司常务副总经理,吉林省吉信国际经贸股份有限公司副总裁,吉林省经贸委、商务厅总经济师,长春市人民政府办公厅副主任(党组成员),中共长春市商业银行委员会书记,长春市商业银行行长,吉林银行董事、副行长、党委委员;兼任吉林省金融学会副会长,东北师范大学、吉林财经大学兼职教授,博士生导师,享受国务院政府特殊津贴专家,长白山技能名师。现任长春高新技术产业(集团)股份有限公司第八届董事会独立董事。","lastUpdated":"2018-06-27"},{"id":"长春高新技术产业(集团)股份有限公司_毛志宏","group":"board","name":"毛志宏","title":"独立董事","isMale":true,"age":"59","degree":"博士","salary":"14.40万","stockAmount":"-","description":"毛志宏,男,1961年4月出生,博士,教授,中共党员。曾任吉林财贸学院教师,现任吉林大学商学院教授、博士生导师、会计系主任,兼任长春高新技术产业(集团)股份有限公司独立董事、北京宇信科技集团股份有限公司独立董事、一汽解放集团股份有限公司独立董事。","lastUpdated":"2018-06-27"},{"id":"长春高新技术产业(集团)股份有限公司_张辉","group":"board","name":"张辉","title":"独立董事","isMale":false,"age":"55","degree":"硕士","salary":"14.40万","stockAmount":"-","description":"张辉,女,汉族,1965年10月出生,中共党员,法律硕士。曾任吉林省行政学院法学部教师,吉林省委党校法学部教师;现任吉林省委党校法学教研部教授;兼任长春仲裁委员会仲裁员,长春市人民政府咨询委员。现任长春高新技术产业(集团)股份有限公司第八届董事会独立董事。","lastUpdated":"2018-06-27"},{"id":"长春高新技术产业(集团)股份有限公司_冯艳","group":"supervisoryCommittee","name":"冯艳","title":"监事会主席","isMale":false,"age":"56","degree":"","salary":"0.00","stockAmount":"-","description":"冯艳,女,1964年10月出生,中共党员,高级会计师,现任长春高新区财政局调研员(正处级)。主要工作经历包括:1986年任吉林省舒兰矿务局营城煤矿财务科会计员;1990年任长春衡器工业公司财务科科长;1997年任吉林省威特集团财务总监;2000年至2018年任长春高新区财政局主任科员、助理调研员、调研员。","lastUpdated":"2018-06-27"},{"id":"长春高新技术产业(集团)股份有限公司_赵树平","group":"supervisoryCommittee","name":"赵树平","title":"监事","isMale":true,"age":"57","degree":"大专","salary":"83.80万","stockAmount":"1200","description":"赵树平,男,1963年1月出生,中共党员,毕业于中共中央党校函授学院,现任长春高新技术产业(集团)股份有限公司总会计师兼审计部长。主要工作经历包括:1984年任长春市控制设备成套厂财务股股长;1988年任长春市机械配套工业公司主管会计;1993年任长春高新技术建设开发公司财务部部长;1998年始历任长春高新技术产业(集团)股份有限公司财务部部长、审计部部长;2003年任长春高新技术产业(集团)股份有限公司副总会计师、审计部部长;2013年至2018年任长春高新技术产业(集团)股份有限公司总会计师、审计部部长。","lastUpdated":"2018-06-27"},{"id":"长春高新技术产业(集团)股份有限公司_李姝","group":"supervisoryCommittee","name":"李姝","title":"职工监事","isMale":false,"age":"48","degree":"","salary":"54.90万","stockAmount":"-","description":"李姝,女,1972年5月出生,中共党员。现任长春高新技术产业(集团)股份有限公司党办副主任。主要工作经历包括:1995年任一汽-花园酒店行政经理、销售总监;2008年至2018年任长春高新房地产开发有限责任公司销售经理、综合管理部部长、总经理助理。","lastUpdated":"2018-06-27"},{"id":"长春高新技术产业(集团)股份有限公司_安吉祥","group":"manager","name":"安吉祥","title":"总经理","isMale":true,"age":"59","degree":"","salary":"190.8万","stockAmount":"5.95万","description":"安吉祥,男,汉族,中共党员,1961年3月出生,现任长春高新技术产业(集团)股份有限公司第八届董事会董事、常务副总经理。主要工作经历包括:长春高新技术产业开发区管委会财政局副局长、长春高新技术产业(集团)股份有限公司财务部部长、长春医药集团总裁助理。","lastUpdated":"2018-06-27"},{"id":"长春高新技术产业(集团)股份有限公司_姜云涛","group":"manager","name":"姜云涛","title":"常务副总经理","isMale":true,"age":"46","degree":"硕士","salary":"169.2万","stockAmount":"2.26万","description":"姜云涛,男,汉族,中共党员,1974年4月出生,吉林大学管理学院工业工程专业工程硕士学位,现任长春高新技术产业(集团)股份有限公司党委副书记。主要工作经历包括:1997年任吉林建工学院城建系团委书记;2001年任长春高新建设开发有限公司办公室主任;2003年任长春高新技术产业发展总公司办公室主任;2007年任长春高新房屋拆迁有限公司经理;2010年任长春高新区建委市政公用设施管理处副处长;2011年任长春高新区南区管委会副主任兼办公室主任;2012年任长春高新区文化旅游园区管理办公室主任;2015年任长春高新技术产业(集团)股份有限公司总经理助理;2016年至2018年任长春高新技术产业(集团)股份有限公司党委副书记。","lastUpdated":"2018-06-27"},{"id":"长春高新技术产业(集团)股份有限公司_张德申","group":"manager","name":"张德申","title":"董事会秘书","isMale":true,"age":"56","degree":"","salary":"129.6万","stockAmount":"3.46万","description":"张德申,男,汉族,1964年4月出生,中共党员,律师。曾任长春高新技术产业(集团)股份有限公司总经理办公室主任、工会主席、党委办公室主任、人事部部长、总经理助理、长春晨光药业有限责任公司总经理。现任长春高新技术产业(集团)股份有限公司董事会秘书、总法律顾问。","lastUpdated":"2018-06-27"},{"id":"长春高新技术产业(集团)股份有限公司_王志刚","group":"manager","name":"王志刚","title":"副总经理","isMale":true,"age":"48","degree":"","salary":"136.8万","stockAmount":"4.65万","description":"王志刚,男,汉族,1972年10月出生,中共党员,高级工程师,现任长春高新技术产业(集团)股份有限公司董事、副总经理、长春高新房地产开发有限公司总经理。主要工作经历包括:2000年任长春星宇集团西宇建设公司经理;2001年任长春星宇集团房地产开发有限责任公司副总经理;2004年历任长春融创置地有限公司副总经理、总经理、董事长;2013年至今任长春高新房地产开发有限公司总经理。","lastUpdated":"2018-06-27"},{"id":"长春高新技术产业(集团)股份有限公司_李秀峰","group":"manager","name":"李秀峰","title":"副总经理","isMale":true,"age":"52","degree":"","salary":"129.6万","stockAmount":"4.59万","description":"李秀峰,男,汉族,1968年12月出生,中共党员,经济师。曾任吉林天河酒精有限公司干部,长春大成玉米开发有限公司干部,长春高新总经理助理,长春高新技术产业(集团)股份有限公司第八届监事会主席。现任长春高新技术产业(集团)股份有限公司副总经理。","lastUpdated":"2018-06-27"},{"id":"长春高新技术产业(集团)股份有限公司_朱兴功","group":"manager","name":"朱兴功","title":"财务总监","isMale":true,"age":"54","degree":"","salary":"129.6万","stockAmount":"4.58万","description":"朱兴功,男,汉族,1966年12月出生,中共党员,会计师。曾任长春高新区管委会财政局干部,吉林华康药业股份有限公司财务总监。现任长春高新技术产业(集团)股份有限公司财务总监。","lastUpdated":"2018-06-27"}],"companyName":"长春高新技术产业(集团)股份有限公司","province":"吉林省","englishName":"Changchun High & New Tech Industry Inc","industry":"医药生物 — 生物制品Ⅱ","website":"www.cchn.com.cn","mainBusiness":"以生物制药、中成药生产及销售、房地产开发为主导产业,辅以开发区基础设施建设、物业管理等。","productsName":["聚乙二醇重组人生长激素注射液","重组人生长激素","注射用重组人促卵泡激素","冻干水痘减毒活疫苗","人用狂犬病疫苗","血栓心脉宁片","银花泌炎灵片","房地产","服务业"],"actualController":"长春新区国有资产监督管理委员会","actualControllerSharePercentage":"15.84%","registeredCapital":"4.05亿元","employeeAmount":"5535","phone":"86-0431-85666367","location":"吉林省长春市朝阳区同志街2400号火炬大厦5层","chineseDescription":"长春高新技术产业(集团)股份有限公司的主营业务以生物制药、中成药生产及销售、房地产开发为主导产业，辅以开发区基础设施建设、物业管理等。公司的主要产品为聚乙二醇重组人生长激素注射液、重组人生长激素、注射用重组人促卵泡激素、冻干水痘减毒活疫苗、人用狂犬病疫苗、血栓心脉宁片、银花泌炎灵片等。","foundedDate":"1993-06-10","goPublicDate":"1996-12-18","companyHistory":"长春高新技术产业（集团）股份有限公司（以下简称本公司）系1993年6月经长春市体改委长体改［1993］33号文批准，由长春高新技术产业发展总公司采取定向募集方式吸收部分社会法人参股组建的股份制企业，公司法人营业执照号为2201071000490；法定代表人：杨占民；注册地址：长春市同志街2400号。公司股票于1996年12月18日在深圳证券交易所挂牌上市。\n　　根据《股权分置改革说明书》的有关内容，和北京市赛德天勤律师事务所“关于长春高新技术产业（集团）股份有限公司股权分置改革相关股东会议之法律意见书”、国务院国有资产监督管理委员会“关于长春高新技术产业发展总公司以长春高新技术产业（集团）股份有限公司国有股权对外出资有关问题的批复”（国资产权2006年1472号）及其他相关文件的批准，2006年12月31日，本公司原股东长春高新技术产业发展总公司将持有的本公司45,475,210.00元的股份出资成立长春高新超达投资有限责任公司。本公司原股东长春高新技术产业发展总公司享有长春高新超达投资有限责任公司70%的股权。\n　　根据本公司控股股东长春高新超达投资有限公司于2015年8月27日发来的《关于股东变更的通知》，长春高新开发区管委会将长春高新技术产业发展总公司及长春创业科技发展有限公司合计持有的全部长春高新超达投资有限公司国有股权无偿划转给龙翔投资控股集团有限公司。至此，本公司的实际控制人变更为龙翔投资控股集团有限公司；本公司的控股股东仍为长春高新超达投资有限公司，最终实际控制人仍为长春市人民政府，未发生变更。\n　　公司2016年5月9日配股发行成功实施，本次公开发行前总股本为131,326,570股，本次发行38,785,695股，发行后总股本为170,112,265股。至此，公司注册资本变更为170,112,265股。\n　　公司以生物制药、中成药生产及房地产开发为主导产业。通过产业结构调整，已经实现了向集生物技术制药、基因概念、化学制药和中成药于一身的综合类集团化企业发展的转变。目前，公司主营业务范围是以生物制药、中成药生产及销售、房地产开发为主导产业，辅以开发区基础设施建设、物业管理等。收起▲","shareholders":[{"organizationId":"00216937","holderName":"长春高新超达投资有限公司","totalShare":"3803.85万","sharePercentage":"18.80%"},{"organizationId":"","holderName":"金磊","totalShare":"2329.17万","sharePercentage":"11.51%"},{"organizationId":"","holderName":"林殿海","totalShare":"660.06万","sharePercentage":"3.26%"},{"organizationId":"T000125370","holderName":"香港中央结算有限公司","totalShare":"554.41万","sharePercentage":"2.74%"},{"organizationId":"T000280241","holderName":"中央汇金资产管理有限责任公司","totalShare":"429.79万","sharePercentage":"2.12%"},{"organizationId":"","holderName":"全国社保基金一一八组合","totalShare":"395.46万","sharePercentage":"1.95%"},{"organizationId":"","holderName":"全国社保基金一零一组合","totalShare":"284.45万","sharePercentage":"1.41%"},{"organizationId":"","holderName":"全国社保基金一零四组合","totalShare":"207.06万","sharePercentage":"1.02%"},{"organizationId":"","holderName":"全国社保基金一一四组合","totalShare":"168.49万","sharePercentage":"0.83%"},{"organizationId":"","holderName":"全国社保基金一一六组合","totalShare":"139.02万","sharePercentage":"0.69%"}],"englishDescription":"Changchun High & New Technology Industries (Group) Inc. is a China-based company principally engaged in bio-pharmaceutical and healthcare businesses. The Company鈥檚 main products include polyethylene glycol recombinant human growth hormone injection, recombinant human growth hormone, recombinant human follicle stimulating hormone for injection, freeze-dried live attenuated varicella vaccines and rabies vaccines for human use, among other. The Company is also involved in real estate development and property management businesses. The Company operates its business mainly in domestic market.","englishIndustry":"Major Drugs","Price to earnings (ttm)":"92.21","Price to sales (ttm)":"27.71","Price to book (mrq)":"23.32","Price to cash flow (ttm)":"--","Total debt to equity (mrq)":"17.64","Lt debt to equity (mrq)":"7.55","Return on investment (ttm)":"31.77","Return on equity (ttm)":"20.28","Income statement":{"Revenue":"7,373.70","Total revenue":"7,373.70","Cost of revenue, total":"1,201.45","Gross profit":"6,172.25","Selling/general/admin. expenses, total":"2,989.60","Research & development":"341.98","Depreciation/amortization":"70.91","Interest exp.(inc.),net-operating, total":"(100.82)","Unusual expense (income)":"13.38","Other operating expenses, total":"(18.98)","Total operating expense":"4,497.52","Operating income":"2,876.18","Gain (loss) on sale of assets":"(10.10)","Other, net":"(46.04)","Net income before taxes":"2,820.04","Provision for income taxes":"470.86","Net income after taxes":"2,349.18","Minority interest":"(574.17)","Net income before extra. items":"1,775.01","Net income":"1,775.01","Income available to com excl extraord":"1,775.01","Income available to com incl extraord":"1,775.01","Diluted net income":"1,775.01","Diluted weighted average shares":"345.67","Diluted eps excluding extraord items":"5.14","Dps - common stock primary issue":"0.50","Diluted normalized eps":"5.19"},"Balance sheet":{"Cash":"0.16","Cash & equivalents":"3,714.16","Short term investments":"215.86","Cash and short term investments":"3,930.18","Accounts receivable - trade, net":"894.77","Total receivables, net":"2,198.54","Total inventory":"1,750.27","Prepaid expenses":"748.25","Other current assets, total":"113.29","Total current assets":"8,740.53","Property/plant/equipment, total - gross":"3,376.23","Accumulated depreciation, total":"(655.84)","Property/plant/equipment, total - net":"2,720.39","Intangibles, net":"450.96","Long term investments":"710.65","Other long term assets, total":"98.82","Total assets":"12,721.35","Accounts payable":"300.63","Accrued expenses":"918.00","Notes payable/short term debt":"665.60","Current port. of  lt debt/capital leases":"0.36","Other current liabilities, total":"1,332.32","Total current liabilities":"3,216.91","Long term debt":"67.60","Total long term debt":"67.60","Total debt":"733.55","Deferred income tax":"3.25","Minority interest":"723.23","Other liabilities, total":"626.01","Total liabilities":"4,637.01","Common stock, total":"202.36","Additional paid-in capital":"3,072.47","Retained earnings (accumulated deficit)":"4,815.71","Other equity, total":"(6.20)","Total equity":"8,084.34","Total liabilities & shareholders' equity":"12,721.35","Total common shares outstanding":"404.72","Tangible book value per share, common eq":"18.86"},"Cash flow":{"Cash receipts":"7,157.78","Cash payments":"(1,005.03)","Cash taxes paid":"(927.33)","Changes in working capital":"(3,290.75)","Cash from operating activities":"1,934.67","Capital expenditures":"(844.86)","Other investing cash flow items, total":"35.15","Cash from investing activities":"(809.71)","Financing cash flow items":"632.00","Total cash dividends paid":"(118.76)","Issuance (retirement) of debt, net":"190.79","Cash from financing activities":"704.02","Foreign exchange effects":"0.14","Net change in cash":"1,829.13"},"keyMetrics":{"Price and Volume":{"Price closing or last bid":"497.00","52 Week High":"513.05","52 Week Low":"159.51","Pricing date":"","10 Day Average Trading Volume":"7.29","Market Capitalization":"201,146.00","52 Week High Date":"","52 Week Low Date":"","3 Month Average Trading Volume":"113.90","Beta":"1.08","1 Day Price Change":"-0.19","13 Week Price Return (Daily)":"66.81","26 Week Price Return (Daily)":"99.60","5 Day Price Return (Daily)":"11.13","52 Week Price Return (Daily)":"201.85","Year To Date Price Return (Daily)":"122.37","Month to Date Price Return (Daily)":"14.17","Price Relative to S&P500 (4 Week)":"10.53","Price Relative to S&P500 (13 Week)":"31.14","Price Relative to S&P500 (26 Week)":"56.34","Price Relative to S&P500 (52 Week)":"105.13","Price Relative to S&P500 (YTD)":"70.08"},"Per Share Data":{"EPS excl. Extra Items (Annual)":"5.14","EPS excl. Extra Items (TTM)":"5.39","EPS Normalized (Annual)":"5.19","Revenue per Share (Annual)":"21.33","Revenue per Share (TTM)":"20.07","Book Value (Per Share Annual)":"19.98","Book Value (Per Share Quarterly)":"21.32","Tangible Book Value (Per Share Annual)":"18.86","Tangible Book Value (Per Share Quarterly)":"19.96","Cash Per Share (Per Share Annual)":"9.71","Cash Per Share (Per Share Quarterly)":"11.27","Cash Flow (Per Share Annual)":"7.21","Cash Flow (Per Share TTM)":"--","Dividend (Per Share Annual)":"0.50","Dividends (Per Share TTM)":"0.50","EBITD (Per Share TTM)":"7.90","EPS Basic excl. Extra Items (Annual)":"5.14","EPS Basic excl. Extra Items (TTM)":"5.39","EPS incl. Extra Items (Annual)":"5.14","EPS incl. Extra Items (TTM)":"5.39","Free Cash Flow (Per Share TTM)":"1.71","Dividend (Per Share 5Y)":"0.41"},"Valuation":{"P/E excl. Extra Items (Annual)":"96.79","P/E excl. Extra Items (TTM)":"92.21","P/E Normalized (Annual)":"95.73","Price to sales (Annual)":"27.28","Price to sales (TTM)":"27.71","Price to Tangible Book (Annual)":"26.35","Price to Tangible Book (Quarterly)":"24.90","Price to Free Cash Flow (Per Share Annual)":"207.14","Price to Cash Flow (Per Share TTM)":"--","Price to Free Cash Flow (Per Share TTM)":"325.34","Price to Book (Annual)":"24.88","Price to Book (Quarterly)":"23.32","P/E Basic excl. Extra Items (TTM)":"50.83","P/E excl. Extra Items High (TTM)":"50.83","P/E excl. Extra Items Low (TTM)":"28.62","P/E incl. Extra Items (TTM)":"92.21","Net Debt (Interim)":"-3,038.06","Net Debt (Annual)":"-3,196.62","Dividend Yield (5Y)":"0.40","Dividend Yield":"0.10","Current Dividend Yield (TTM)":"0.10"},"Financial Strength":{"Free Cash Flow (Annual)":"971.05","Current Ratio (Annual)":"2.72","Net Interest coverage (Annual)":"--","Long Term Debt/Equity (Annual)":"0.84","Payout Ratio (Annual)":"11.40","Quick Ratio (Annual)":"2.17","Total Debt/Total Equity (Annual)":"9.07","Current EV/Free Cash Flow (Annual)":"130.08","Current EV/Free Cash Flow (TTM)":"--","Current Ratio (Quarterly)":"2.64","Long Term Debt/Equity (Quarterly)":"7.55","Quick Ratio (Quarterly)":"2.17","Total Debt/Total Equity (Quarterly)":"17.64","Free Cash Flow (TTM)":"618.26","Net Interest Coverage (TTM)":"--","Payout Ratio (TTM)":"10.36"},"Margins":{"Gross Margin (Annual)":"83.71","Gross Margin (TTM)":"84.98","Net Profit Margin % (Annual)":"31.86","Net Profit Margin (TTM)":"33.17","Operating Margin (Annual)":"39.01","Operating Margin (TTM)":"40.62","Pretax Margin (TTM)":"39.81","Pretax Margin (Annual)":"38.24","Operating Margin (5Y)":"32.75","Pretax Margin (5Y)":"32.24","Free Operating Cash Flow/Revenue (5Y)":"6.91","Free Operating Cash Flow/Revenue (TTM)":"8.52","Gross Margin (5Y)":"81.52","Net Profit Margin (5Y)":"26.88"},"Management Effectiveness":{"Return on Assets (Annual)":"21.23","Return on Equity (TTM)":"20.28","Return on Average Equity (Annual)":"26.53","Return on Average equity (TTM)":"27.59","Return on Investment (Annual)":"32.97","Return on Investment (TTM)":"31.77","Return on Average Assets (5Y)":"17.15","Return on Average Equity (5Y)":"21.38","Return on Investment (5Y)":"27.98","Asset Turnover (Annual)":"0.67","Asset Turnover (TTM)":"0.61","Inventory Turnover (Annual)":"0.67","Inventory Turnover (TTM)":"0.61","Net Income/Employee (Annual)":"442,949.60","Net Income/Employee (TTM)":"435,048.50","Receivables Turnover (Annual)":"9.15","Receivables Turnover (TTM)":"7.79","Revenue/Employee (Annual)":"1,390,346.00","Revenue/Employee (TTM)":"1,311,578.00"},"Growth":{"Revenue Growth (Quarterly YoY)":"-6.43","Revenue Growth Rate (5Y)":"26.66","EPS Growth (Quarterly YoY)":"24.91","EPS Growth (TTM YoY)":"57.90","EPS Growth Rate (5Y)":"37.17","Dividend Growth Rate (3Y)":"7.72","Revenue Growth (TTM YoY)":"18.65","Revenue Growth (Per Share 5Y)":"23.19","Revenue Growth Rate (3Y)":"36.53","EPS Growth Rate (3Y)":"53.31","Book Value Growth Rate (Per Share 5Y)":"32.71","Tangible Book Value Total Equity CAGR (5Y)":"42.42","Capital Spending growth rate 5 year":"52.72","EBITDA CAGR (5Y)":"37.16","EBITDA Interim CAGR (5Y)":"38.02","Free Operating Cash Flow CAGR (5Y)":"66.85","Total Debt CAGR (5Y)":"47.98","Net Profit Margin Growth Rate (5Y)":"10.16"},"Income Statement":{"Revenue (Annual)":"7,373.70","Revenue (TTM)":"7,259.59","EBITD (Annual)":"2,930.48","EBITD (TTM)":"2,858.88","Earnings Before Taxes (Annual)":"2,820.04","Earnings Before Taxes (TTM)":"2,890.19","Net Income to Common (Annual)":"1,775.01","Net Income to Common (TTM)":"1,952.41","Earnings Before Taxes Normalized (Annual)":"2,843.53","Net Income Available to Common Normalized (Annual)":"1,794.57","Diluted Normalized EPS excl. Extra Items (TTM)":"5.42"}}}